March, 2011
No. 96 (3)

Editorials

Mutant BCR-ABL clones in chronic myeloid leukemia

Michael S. Mathisen, Hagop M. Kantarjian, Jorge Cortes, Elias Jabbour

https://doi.org/10.3324/haematol.2010.039560

Articles

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy

Benjamin Hanfstein, Martin C. Müller, Sebastian Kreil, Thomas Ernst, Thomas Schenk, Christian Lorentz, Uwe Schwindel, Armin Leitner, Rüdiger Hehlmann, Andreas Hochhaus

https://doi.org/10.3324/haematol.2010.030999

Myeloproliferative Neoplasms

The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms

Damla Olcaydu, Elisa Rumi, Ashot Harutyunyan, Francesco Passamonti, Daniela Pietra, Cristiana Pascutto, Tiina Berg, Roland Jäger, Emma Hammond, Mario Cazzola, Robert Kralovics

https://doi.org/10.3324/haematol.2010.034488

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Esperanza Such, José Cervera, Dolors Costa, Francesc Solé, Teresa Vallespí, Elisa Luño, Rosa Collado, María J. Calasanz, Jesús M. Hernández-Rivas, Juan C. Cigudosa, Benet Nomdedeu, Mar Mallo, Felix Carbonell, Javier Bueno, María T. Ardanaz, Fernando Ramos, Mar Tormo, Reyes Sancho-Tello, Consuelo del Cañizo, Valle Gómez, Victor Marco, Blanca Xicoy, Santiago Bonanad, Carmen Pedro, Teresa Bernal, Guillermo F. Sanz

https://doi.org/10.3324/haematol.2010.030957

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia

Iris H.I.M. Hollink, Marry M. van den Heuvel-Eibrink, Susan T.C.J.M. Arentsen-Peters, Martin Zimmermann, Justine K. Peeters, Peter J.M. Valk, Brian V. Balgobind, Edwin Sonneveld, Gertjan J.L. Kaspers, Eveline S.J.M. de Bont, Jan Trka, Andre Baruchel, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C. Michel Zwaan

https://doi.org/10.3324/haematol.2010.031336

Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations

Anna Savoia, Annalisa Pastore, Daniela De Rocco, Elisa Civaschi, Mariateresa Di Stazio, Roberta Bottega, Federica Melazzini, Valeria Bozzi, Alessandro Pecci, Silvana Magrin, Carlo L. Balduini, Patrizia Noris

https://doi.org/10.3324/haematol.2010.032631

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies

Katayoun Rezvani, Agnes S.M. Yong, Stephan Mielke, Behnam Jafarpour, Bipin N. Savani, Robert Q. Le, Rhoda Eniafe, Laura Musse, Carol Boss, Roger Kurlander, A. John Barrett

https://doi.org/10.3324/haematol.2010.031674

The JAK2 V617F somatic mutation, mortality and cancer risk in the general population

Camilla Nielsen, Henrik S. Birgens, Børge G. Nordestgaard, Lasse Kjær, Stig E. Bojesen

https://doi.org/10.3324/haematol.2010.033191

Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma

Kengo Takeuchi, Manabu Soda, Yuki Togashi, Yasunori Ota, Yasunobu Sekiguchi, Satoko Hatano, Reimi Asaka, Masaaki Noguchi, Hiroyuki Mano

https://doi.org/10.3324/haematol.2010.033514

IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach

Polina Stepensky, Michael Weintraub, Asaf Yanir, Shoshana Revel-Vilk, Frank Krux, Kirsten Huck, Rene M. Linka, Avraham Shaag, Orly Elpeleg, Arndt Borkhardt, Igor B. Resnick

https://doi.org/10.3324/haematol.2010.033910

Letters to the Editor

Myeloproliferative Neoplasms

Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis

Roberta Zanotti, Patrizia Bonadonna, Massimiliano Bonifacio, Anna Artuso, Donatella Schena, Maurizio Rossini, Omar Perbellini, Sabrina Colarossi, Marco Chilosi, Giovanni Pizzolo

https://doi.org/10.3324/haematol.2010.034553

Online Only Articles


Chronic Myeloid Leukemia

Myeloproliferative Neoplasms

Brief Reports

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients

Elisa Rumi, Francesco Passamonti, Chiara Elena, Daniela Pietra, Luca Arcaini, Cesare Astori, Silvia Zibellini, Emanuela Boveri, Cristiana Pascutto, Mario Lazzarino

https://doi.org/10.3324/haematol.2010.033779

Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis

Todd M. Wilson, Irina Maric, Olga Simakova, Yun Bai, Eunice Ching Chan, Nicolas Olivares, Melody Carter, Dragan Maric, Jamie Robyn, Dean D. Metcalfe

https://doi.org/10.3324/haematol.2010.031690

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients

María E. Sarasquete, Norma C. Gutiérrez, Irena Misiewicz-Krzeminska, Bruno Paiva, María C. Chillón, Miguel Alcoceba, Ramón García-Sanz, Jesús M. Hernández, Marcos González, Jesús F. San-Miguel

https://doi.org/10.3324/haematol.2010.033845

Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies

Marleen M. van Loenen, Renate de Boer, Renate S. Hagedoorn, Esther H.M. van Egmond, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

https://doi.org/10.3324/haematol.2010.025916

Decision Making and Problem Solving

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

Matteo G. Della Porta, Luca Malcovati, Corinna Strupp, Ilaria Ambaglio, Andrea Kuendgen, Esther Zipperer, Erica Travaglino, Rosangela Invernizzi, Cristiana Pascutto, Mario Lazzarino, Ulrich Germing, Mario Cazzola

https://doi.org/10.3324/haematol.2010.033506